Literature DB >> 24778024

Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer.

Tsu-Yao Cheng1, Ming-Shiang Wu, Jaw-Town Lin, Ming-Tsan Lin, Chia-Tung Shun, Kuo-Tai Hua, Min-Liang Kuo.   

Abstract

BACKGROUND: Formyl peptide receptor 1 (FPR1) as a regulator of innate inflammatory response has been implicated in tumor progression of gliomas. The purpose of the present study was to evaluate the prognostic significance and the ligand-receptor interaction of FPR1 in gastric cancer (GC). PATIENTS AND METHODS: FPR1 was immunohistochemically-analyzed in tissue sections originating from 116 GC patients. Reverse transcription-polymerase chain reaction (RT-PCR) was used for the assessment of interaction between FPR1 and the FPR1 ligand annexin A1 (AnxA1) in GC cells.
RESULTS: High FPR1 expression was significantly associated with stage IV disease, submucosal invasion, serosal invasion, and clinical outcome of GC. Multivariate analysis showed that high FPR1 expression was an independent risk factor of poor overall survival in GC patients. FPR1 expression increased significantly when AnxA1 overexpression was present in GC cells. A positive feedback regulation of FPR1 was involved in the AnxA1-FPR1 signal transduction.
CONCLUSION: FPR1 expression may be used as a novel indicator to predict outcome in GC patients after gastrectomy.

Entities:  

Keywords:  Formyl peptide receptor 1; annexin A1; gastric cancer; survival; tumor progression

Mesh:

Substances:

Year:  2014        PMID: 24778024

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

1.  Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Ni Cheng; Richard D Ye; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2014-10-17       Impact factor: 5.858

Review 2.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

3.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

4.  Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways.

Authors:  Nella Prevete; Federica Liotti; Anna Illiano; Angela Amoresano; Piero Pucci; Amato de Paulis; Rosa Marina Melillo
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

Review 5.  Regulation of inflammation by members of the formyl-peptide receptor family.

Authors:  Keqiang Chen; Zhiyao Bao; Wanghua Gong; Peng Tang; Teizo Yoshimura; Ji Ming Wang
Journal:  J Autoimmun       Date:  2017-07-06       Impact factor: 7.094

6.  Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists.

Authors:  Margherita Mastromarino; Liliya N Kirpotina; Igor A Schepetkin; Mark T Quinn; Enza Lacivita; Marcello Leopoldo
Journal:  Medchemcomm       Date:  2019-10-07       Impact factor: 3.597

7.  The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.

Authors:  Igor Snapkov; Carl Otto Öqvist; Yngve Figenschau; Per Kogner; John Inge Johnsen; Baldur Sveinbjørnsson
Journal:  BMC Cancer       Date:  2016-07-18       Impact factor: 4.430

8.  FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.

Authors:  Xi-Lu Hou; Cheng-Dong Ji; Jun Tang; Yan-Xia Wang; Dong-Fang Xiang; Hai-Qing Li; Wei-Wei Liu; Jiao-Xue Wang; He-Zhong Yan; Yan Wang; Peng Zhang; You-Hong Cui; Ji-Ming Wang; Xiu-Wu Bian; Wei Liu
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

9.  High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.

Authors:  Albin Rudisch; Matthew Richard Dewhurst; Luminita Gabriela Horga; Nina Kramer; Nathalie Harrer; Meng Dong; Heiko van der Kuip; Andreas Wernitznig; Andreas Bernthaler; Helmut Dolznig; Wolfgang Sommergruber
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.

Authors:  Shu-Qin Li; Ning Su; Ping Gong; Hai-Bo Zhang; Jin Liu; Ding Wang; Yan-Ping Sun; Yan Zhang; Feng Qian; Bo Zhao; Yang Yu; Richard D Ye
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.